Golzar Hemmati
-
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 2
-
- Cancer Mechanisms and Therapy 2
-
- Protein Degradation and Inhibitors 2
- PI3K/AKT/mTOR signaling in cancer 2
- Melanoma and MAPK Pathways 2
-
- Multiple Myeloma Research and Treatments 3
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Trever G. BivonaVictor OlivasDana S. NeelAndrey RymarXiaohong ChenRoss A. OkimotoElton ChanLuping Lin
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Blood (2 papers)Cancer Research (5 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Golzar Hemmati
8 papers receiving 145 citations
Peers
Comparison fields: 5 of 36
- Oncology 75
- Pulmonary and Respiratory Medicine 65
- Cancer Research 27
- Pathology and Forensic Medicine 30
- Molecular Biology 99
Countries citing papers authored by Golzar Hemmati
This map shows the geographic impact of Golzar Hemmati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Golzar Hemmati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Golzar Hemmati more than expected).
Fields of papers citing papers by Golzar Hemmati
This network shows the impact of papers produced by Golzar Hemmati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Golzar Hemmati. The network helps show where Golzar Hemmati may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Golzar Hemmati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 0 | |
| 2 | 2021 | 1 | |
| 3 | 2021 | 1 | |
| 4 | 2021 | 1 | |
| 5 | 2019 | 11 | |
| 6 | 2018 | 63 | |
| 7 | 2018 | 12 | |
| 8 | 2018 | 1 | |
| 9 | 2016 | 57 |
About Golzar Hemmati
Golzar Hemmati is a scholar working on Hematology, Oncology and Biotechnology, having authored 9 papers that have together received 147 indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), Multiple Myeloma Research and Treatments (3 papers), Cancer Mechanisms and Therapy (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Protein Degradation and Inhibitors (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Melanoma and MAPK Pathways (2 papers). The work is most often cited by research in Oncology (75 citations), Pulmonary and Respiratory Medicine (65 citations) and Cancer Research (27 citations). Golzar Hemmati has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Trever G. Bivona, Victor Olivas, Dana S. Neel, Andrey Rymar, Xiaohong Chen, Ross A. Okimoto, Elton Chan, Luping Lin, Gideon Bollag and Nilanjana Chatterjee. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.